loader

kura oncology

LATEST ARTICLES

Kura Oncology Presents Update on Positive Phase 2 Trial of Tipifarnib in HRAS Mutant HNSCC and Preliminary Results in HRAS Mutant SCC

pharmaceutical investing

Kura Oncology Announces Commencement of Public Offering of Common Stock

Kura Oncology Reports First Quarter 2018 Financial Results and Provides Corporate Update

pharmaceutical investing

Kura Oncology Provides Regulatory Update on Tipifarnib and Reports Fourth Quarter and Full Year 2017 Financial Results

Kura Oncology Provides Update on Phase 2 Trial of Tipifarnib in HRAS Mutant Head and Neck Cancer

Kura Oncology Shares New Findings for Development of Tipifarnib

pharmaceutical investing

Kura Oncology Gets US Patent for Tipifarnib in Head and Neck Cancer

Latest News

More News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES